Antony Mattessich
Director/Board Member at AURA BIOSCIENCES, INC.
Net worth: 1 M $ as of 2024-05-30
Antony Mattessich active positions
| Companies | Position | Start | End |
|---|---|---|---|
| AURA BIOSCIENCES, INC. | Director/Board Member | 2021-09-28 | - |
| Independent Dir/Board Member | 2021-09-28 | - |
Career history of Antony Mattessich
Former positions of Antony Mattessich
| Companies | Position | Start | End |
|---|---|---|---|
| OCULAR THERAPEUTIX, INC. | Director/Board Member | 2017-05-31 | 2024-04-14 |
| Chief Executive Officer | 2017-07-31 | 2024-04-14 | |
| President | 2017-07-25 | 2024-04-14 | |
Mundipharma International Ltd.
 Mundipharma International Ltd. Pharmaceuticals: MajorHealth Technology Mundipharma International Ltd. develops and produces pharmaceutical products. It offers analgesics, oncology, respiratory, gastrointestinal, and cardiovascular drugs. The company was founded in 1952 and is headquartered in Cambridge, the United Kingdom. | Director/Board Member | 2017-07-31 | 2017-12-17 |
| Chief Executive Officer | 2017-07-31 | 2017-12-17 | |
| Corporate Officer/Principal | 2008-12-31 | 2017-07-31 | |
| President | 2017-07-31 | 2017-12-17 | |
Napp Pharmaceutical Holdings Ltd.
 Napp Pharmaceutical Holdings Ltd. Pharmaceuticals: MajorHealth Technology Napp Pharmaceutical Holdings Ltd. develops and provides medicines to patients. It offers prescription products for respiratory diseases such as asthma, inflammatory conditions, Crohn's disease, ulcerative colitis, ankylosing spondylitis, rheumatoid arthritis and psoriasis, as well as pain management, blood cancers, and cardiovascular conditions. The company was founded on December 19, 1997 and is headquartered in Cambridge, the United Kingdom. | Director/Board Member | 2004-12-31 | 2011-04-30 |
| Chief Executive Officer | 2004-12-31 | 2011-04-30 | |
| NOVARTIS AG | Corporate Officer/Principal | 2002-12-31 | 2004-12-31 |
| BRISTOL-MYERS SQUIBB COMPANY | Director/Board Member | - | - |
Training of Antony Mattessich
| The Trustees of Columbia University in The City of New York | Graduate Degree |
| University of California, Berkeley | Undergraduate Degree |
Statistics
International
| United States | 6 |
| United Kingdom | 3 |
| Switzerland | 2 |
Operational
| Director/Board Member | 5 |
| Chief Executive Officer | 3 |
| Corporate Officer/Principal | 2 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| OCULAR THERAPEUTIX, INC. | Health Technology |
| NOVARTIS AG | Health Technology |
| AURA BIOSCIENCES, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Private companies | 2 |
|---|---|
Napp Pharmaceutical Holdings Ltd.
Napp Pharmaceutical Holdings Ltd. Pharmaceuticals: MajorHealth Technology Napp Pharmaceutical Holdings Ltd. develops and provides medicines to patients. It offers prescription products for respiratory diseases such as asthma, inflammatory conditions, Crohn's disease, ulcerative colitis, ankylosing spondylitis, rheumatoid arthritis and psoriasis, as well as pain management, blood cancers, and cardiovascular conditions. The company was founded on December 19, 1997 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Mundipharma International Ltd.
Mundipharma International Ltd. Pharmaceuticals: MajorHealth Technology Mundipharma International Ltd. develops and produces pharmaceutical products. It offers analgesics, oncology, respiratory, gastrointestinal, and cardiovascular drugs. The company was founded in 1952 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Antony Mattessich
- Experience
